Clinical effect of aminoglutethimide, medical adrenalectomy, in treatment of 43 patients with advanced prostatic carcinoma

Joseph R. Drago, Richard J. Santen, Allan Lipton, Thomas J. Worgul, Harold A. Harvey, Alice Boucher, Andrea Manni, Thomas J. Rohner

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

The initial treatment of patients with Stage D prostatic carcinoma with orchiectomy or estrogens is successful in giving objective and subjective improvement for variable periods of time. However, after initial endocrine treatment patients generally relapse, and go on to further progression of their disease. However, a subgroup of approximately 22% of these Stage D prostatic cancer patients respond to either surgical adrenalectomy or hypophysectomy, indicating some degree of continued hormonal responsiveness. Forty‐three previously castrated patients with Stage D prostatic carcinoma were treated with 1000 mg of aminoglutethimide and 40 mg of hydrocortisone daily and have been evaluated using the criteria of the National Prostatic Cancer Project. Progression of disease after initial hormonal therapy has varied from 3 to 25 months. One patient has had a complete response, and continues in remission after 290 weeks of therapy. Partial objective responses have been observed in 6 patients, and 10 patients have remained objectively stable for an average of 35 weeks in this latter group.

Original languageEnglish (US)
Pages (from-to)1447-1450
Number of pages4
JournalCancer
Volume53
Issue number7
DOIs
StatePublished - Apr 1 1984

Fingerprint

Aminoglutethimide
Adrenalectomy
Carcinoma
Therapeutics
Disease Progression
Prostatic Neoplasms
Hypophysectomy
Orchiectomy
Hydrocortisone
Estrogens
Recurrence

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Drago, Joseph R. ; Santen, Richard J. ; Lipton, Allan ; Worgul, Thomas J. ; Harvey, Harold A. ; Boucher, Alice ; Manni, Andrea ; Rohner, Thomas J. / Clinical effect of aminoglutethimide, medical adrenalectomy, in treatment of 43 patients with advanced prostatic carcinoma. In: Cancer. 1984 ; Vol. 53, No. 7. pp. 1447-1450.
@article{c8cf60473c184f6690089d40aa53c2b0,
title = "Clinical effect of aminoglutethimide, medical adrenalectomy, in treatment of 43 patients with advanced prostatic carcinoma",
abstract = "The initial treatment of patients with Stage D prostatic carcinoma with orchiectomy or estrogens is successful in giving objective and subjective improvement for variable periods of time. However, after initial endocrine treatment patients generally relapse, and go on to further progression of their disease. However, a subgroup of approximately 22{\%} of these Stage D prostatic cancer patients respond to either surgical adrenalectomy or hypophysectomy, indicating some degree of continued hormonal responsiveness. Forty‐three previously castrated patients with Stage D prostatic carcinoma were treated with 1000 mg of aminoglutethimide and 40 mg of hydrocortisone daily and have been evaluated using the criteria of the National Prostatic Cancer Project. Progression of disease after initial hormonal therapy has varied from 3 to 25 months. One patient has had a complete response, and continues in remission after 290 weeks of therapy. Partial objective responses have been observed in 6 patients, and 10 patients have remained objectively stable for an average of 35 weeks in this latter group.",
author = "Drago, {Joseph R.} and Santen, {Richard J.} and Allan Lipton and Worgul, {Thomas J.} and Harvey, {Harold A.} and Alice Boucher and Andrea Manni and Rohner, {Thomas J.}",
year = "1984",
month = "4",
day = "1",
doi = "10.1002/1097-0142(19840401)53:7<1447::AID-CNCR2820530703>3.0.CO;2-G",
language = "English (US)",
volume = "53",
pages = "1447--1450",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

Clinical effect of aminoglutethimide, medical adrenalectomy, in treatment of 43 patients with advanced prostatic carcinoma. / Drago, Joseph R.; Santen, Richard J.; Lipton, Allan; Worgul, Thomas J.; Harvey, Harold A.; Boucher, Alice; Manni, Andrea; Rohner, Thomas J.

In: Cancer, Vol. 53, No. 7, 01.04.1984, p. 1447-1450.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical effect of aminoglutethimide, medical adrenalectomy, in treatment of 43 patients with advanced prostatic carcinoma

AU - Drago, Joseph R.

AU - Santen, Richard J.

AU - Lipton, Allan

AU - Worgul, Thomas J.

AU - Harvey, Harold A.

AU - Boucher, Alice

AU - Manni, Andrea

AU - Rohner, Thomas J.

PY - 1984/4/1

Y1 - 1984/4/1

N2 - The initial treatment of patients with Stage D prostatic carcinoma with orchiectomy or estrogens is successful in giving objective and subjective improvement for variable periods of time. However, after initial endocrine treatment patients generally relapse, and go on to further progression of their disease. However, a subgroup of approximately 22% of these Stage D prostatic cancer patients respond to either surgical adrenalectomy or hypophysectomy, indicating some degree of continued hormonal responsiveness. Forty‐three previously castrated patients with Stage D prostatic carcinoma were treated with 1000 mg of aminoglutethimide and 40 mg of hydrocortisone daily and have been evaluated using the criteria of the National Prostatic Cancer Project. Progression of disease after initial hormonal therapy has varied from 3 to 25 months. One patient has had a complete response, and continues in remission after 290 weeks of therapy. Partial objective responses have been observed in 6 patients, and 10 patients have remained objectively stable for an average of 35 weeks in this latter group.

AB - The initial treatment of patients with Stage D prostatic carcinoma with orchiectomy or estrogens is successful in giving objective and subjective improvement for variable periods of time. However, after initial endocrine treatment patients generally relapse, and go on to further progression of their disease. However, a subgroup of approximately 22% of these Stage D prostatic cancer patients respond to either surgical adrenalectomy or hypophysectomy, indicating some degree of continued hormonal responsiveness. Forty‐three previously castrated patients with Stage D prostatic carcinoma were treated with 1000 mg of aminoglutethimide and 40 mg of hydrocortisone daily and have been evaluated using the criteria of the National Prostatic Cancer Project. Progression of disease after initial hormonal therapy has varied from 3 to 25 months. One patient has had a complete response, and continues in remission after 290 weeks of therapy. Partial objective responses have been observed in 6 patients, and 10 patients have remained objectively stable for an average of 35 weeks in this latter group.

UR - http://www.scopus.com/inward/record.url?scp=0021347052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021347052&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19840401)53:7<1447::AID-CNCR2820530703>3.0.CO;2-G

DO - 10.1002/1097-0142(19840401)53:7<1447::AID-CNCR2820530703>3.0.CO;2-G

M3 - Article

C2 - 6697289

AN - SCOPUS:0021347052

VL - 53

SP - 1447

EP - 1450

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 7

ER -